HCA Healthcare, Inc.
HCAHCA Healthcare, Inc. (historically known as Hospital Corporation of America) is an American global for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owned and operated 186 hospitals and approximately 2,400 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 20 states and the United Kingdom. As of 2024, HCA Healthcare is ranked #61 on the Fortune 500 rankings of the largest United States corporations by total revenue. In the 1990s, the company engaged in illegal accounting and other crimes that resulted in the payment of more than $2 billion in federal fines and other penalties, and the dismissal of the CEO Rick Scott by the board of directors.
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Jul 24, 2026
10dMarket Overview
Stock performance and key metrics
2 upcoming, 0 past
HCA Reports Financial Results
Filed: 2026-07-14 AccNo: 0001193125-26-302539 Size: 376 KB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
SourceHCA Earnings Report
EPS Est: $7.37 | FQ end 2026-06
How HCA's past catalysts played out
No drugs found in this phase.
Full breakdown — the signals behind the verdict
Frequently asked questions
When is HCA Healthcare, Inc.'s next FDA catalyst?→
HCA Healthcare, Inc.'s (HCA) next tracked catalyst is a Earnings expected July 24, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track HCA biotech catalysts?→
Add HCA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow HCA Healthcare, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.